Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Comparative, Single-blinded, Multi-center Study Evaluating JointRep® and Microfracture in Repair of Focal Articular Cartilage Lesions on the Femoral Condyle or Trochlea, The JMAC Trial.

NCT04840147 is registered in ClinicalTrials.gov with Oligo Medic Pty Ltd as lead sponsor.

NCT NCT04840147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Comparative, Single-blinded, Multi-center Study Evaluating JointRep® and Microfracture in Repair of Focal Articular Cartilage Lesions on the Femoral Condyle or Trochlea, The JMAC Trial.
Lead sponsor
Oligo Medic Pty Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
September 22, 2021
Completion date
December 31, 2025
Enrollment
185 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage defect, articular cartilage disorder of knee, chondral defect